MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

20 Jul 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated July 20, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..